Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Perfetto

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Leukemia|June 1, 1997
The common TEL/AML1 rearrangement does not represent a frequent event in acute lymphoblastic leukaemia occuring in children with Down syndromeC Lanza, G Volpe, G Basso, et al.
International Journal of Immunopathology and Pharmacology|June 12, 2003
Immune system alterations in lung cancer patientsG Mazzoccoli, M Grilli, S Carughi, et al.
Biomedical Instrumentation & Technology|April 9, 1999
Chronomes, time structures, for chronobioengineering for "a full life"G Cornélissen, F Halberg, O Schwartzkopff, et al.
Leukemia Research|May 1, 1996
Persistence of E2A/PBX1 transcripts in t(1;19) childhood acute lymphoblastic leukemia: correlation with chemotherapy intensity and clinical outcomeC Lanza, E Gottardi, G Gaidano, et al.
British Journal of Haematology|May 1, 1997
Outcome and lineage involvement in t(12;21) childhood acute lymphoblastic leukaemiaC Lanza, G Volpe, G Basso, et al.
Hepatology (Baltimore, Md.)|June 30, 2001
Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosisG La Villa, G Barletta, P Pantaleo, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 16, 2011
The Florence Register of amyloidosis: 20 years' experience in the diagnosis and treatment of the disease in the Florence district areaA Cania, F Bergesio, G Curciarello, et al.
Arthritis Research & Therapy|November 10, 2005
Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritisS Guiducci, A Del Rosso, M Cinelli, et al.
Journal of Internal Medicine|October 28, 2014
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imagingA Barison, G D Aquaro, N R Pugliese, et al.
Anti-Cancer Drugs|August 21, 2002
Raltitrexed plus oxaliplatin as first-line chemotherapy in metastatic colorectal carcinoma: a multicentric phase II trialB Neri, L Doni, C Fulignati, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Leukemia|June 1, 1997
The common TEL/AML1 rearrangement does not represent a frequent event in acute lymphoblastic leukaemia occuring in children with Down syndromeC Lanza, G Volpe, G Basso, et al.
International Journal of Immunopathology and Pharmacology|June 12, 2003
Immune system alterations in lung cancer patientsG Mazzoccoli, M Grilli, S Carughi, et al.
Biomedical Instrumentation & Technology|April 9, 1999
Chronomes, time structures, for chronobioengineering for "a full life"G Cornélissen, F Halberg, O Schwartzkopff, et al.
Leukemia Research|May 1, 1996
Persistence of E2A/PBX1 transcripts in t(1;19) childhood acute lymphoblastic leukemia: correlation with chemotherapy intensity and clinical outcomeC Lanza, E Gottardi, G Gaidano, et al.
British Journal of Haematology|May 1, 1997
Outcome and lineage involvement in t(12;21) childhood acute lymphoblastic leukaemiaC Lanza, G Volpe, G Basso, et al.
Hepatology (Baltimore, Md.)|June 30, 2001
Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosisG La Villa, G Barletta, P Pantaleo, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 16, 2011
The Florence Register of amyloidosis: 20 years' experience in the diagnosis and treatment of the disease in the Florence district areaA Cania, F Bergesio, G Curciarello, et al.
Arthritis Research & Therapy|November 10, 2005
Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritisS Guiducci, A Del Rosso, M Cinelli, et al.
Journal of Internal Medicine|October 28, 2014
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imagingA Barison, G D Aquaro, N R Pugliese, et al.
Anti-Cancer Drugs|August 21, 2002
Raltitrexed plus oxaliplatin as first-line chemotherapy in metastatic colorectal carcinoma: a multicentric phase II trialB Neri, L Doni, C Fulignati, et al.
Pageof 6